Readhead B, Dudley J. Translational bioinformatics approaches to drug development. Adv Wound Care (New Rochelle). 2013;2(9):470–89.
Article
Google Scholar
Jin G, Wong STC. Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines. Drug Discov Today. 2014;19(5):637–44.
Article
PubMed Central
PubMed
Google Scholar
Shim JS, Liu JO. Recent advances in drug repositioning for the discovery of new anticancer drugs. Int J Biol Sci. 2014;10(7):654–63.
Article
PubMed Central
CAS
PubMed
Google Scholar
Stenvang J, Kümler I, Nygård SB, Smith DH, Nielsen D, Brünner N, et al. Biomarker-guided repurposing of chemotherapeutic drugs for cancer therapy: a novel strategy in drug development. Front Oncol. 2013;3:313.
Article
PubMed Central
PubMed
Google Scholar
Munson J, Bonner M, Fried L, Hofmekler J, Arbiser J, Bellamkonda R. Identifying new small molecule anti-invasive compounds for glioma treatment. Cell Cycle. 2013;12(14):2200–9.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bellera CL, Sbaraglini ML, Balcazar DE, Fraccaroli L, Vanrell MC, Casassa AF, et al. High-throughput drug repositioning for the discovery of new treatments for Chagas disease. Mini Rev Med Chem. 2015;15(3):182–93.
Article
CAS
PubMed
Google Scholar
Shu C-W, Liu P-F, Huang C-M. High throughput screening for drug discovery of autophagy modulators. Comb Chem High Throughput Screen. 2012;15(9):721–9.
Article
CAS
PubMed
Google Scholar
Li J, Zheng S, Chen B, Butte AJ, Swamidass SJ, Lu Z. A survey of current trends in computational drug repositioning. Brief Bioinform. 2016 Jan;17(1):2-12.
Menden MP, Iorio F, Garnett M, McDermott U, Benes CH, Ballester PJ, et al. Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties. PLoS One. 2013;8(4), e61318.
Article
PubMed Central
CAS
PubMed
Google Scholar
Gottlieb A, Stein GY, Ruppin E, Sharan R. PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol. 2011;7:496.
Article
PubMed Central
PubMed
Google Scholar
Grover MP, Ballouz S, Mohanasundaram KA, George RA, Sherman CDH, Crowley TM, et al. Identification of novel therapeutics for complex diseases from genome-wide association data. BMC Med Genomics. 2014;7 Suppl 1:S8.
Article
PubMed
Google Scholar
Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313(5795):1929–35.
Article
CAS
PubMed
Google Scholar
Huang H, Nguyen T, Ibrahim S, Shantharam S, Yue Z, Chen JY. DMAP: a connectivity map database to enable identification of novel drug repositioning candidates. BMC Bioinformatics. 2015;16 Suppl 13:S4.
Article
PubMed
Google Scholar
Yu J, Putcha P, Silva JM. Recovering drug-induced apoptosis subnetwork from Connectivity Map data. Biomed Res Int. 2015;2015:708563.
PubMed Central
PubMed
Google Scholar
Lv J, Zhu B, Zhang L, Xie Q, Zhuo W. Detection and screening of small molecule agents for overcoming Sorafenib resistance of hepatocellular carcinoma: a bioinformatics study. Int J Clin Exp Med. 2015;8(2):2317–25.
PubMed Central
CAS
PubMed
Google Scholar
Zhang M, Luo H, Xi Z, Rogaeva E. Drug repositioning for diabetes based on “omics” data mining. PLoS One. 2015;10(5), e0126082.
Article
PubMed Central
PubMed
Google Scholar
Manzotti G, Parenti S, Ferrari-Amorotti G, Soliera AR, Cattelani S, Montanari M, et al. Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the Connectivity Map database. Cell Cycle. 2015 Jun 23;0
Yu YP, Landsittel D, Jing L, Nelson J, Ren B, Liu L, et al. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol. 2004;22(14):2790–9.
Article
CAS
PubMed
Google Scholar
Arredouani MS, Lu B, Bhasin M, Eljanne M, Yue W, Mosquera J-M, et al. Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer. Clin Cancer Res. 2009;15(18):5794–802.
Article
CAS
PubMed
Google Scholar
Satake H, Tamura K, Furihata M, Anchi T, Sakoda H, Kawada C, et al. The ubiquitin-like molecule interferon-stimulated gene 15 is overexpressed in human prostate cancer. Oncol Rep. 2010;23(1):11–6.
CAS
PubMed
Google Scholar
Yegnasubramanian S, Haffner MC, Zhang Y, Gurel B, Cornish TC, Wu Z, et al. DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity. Cancer Res. 2008;68(21):8954–67.
Article
PubMed Central
CAS
PubMed
Google Scholar
Nanni S, Priolo C, Grasselli A, D’Eletto M, Merola R, Moretti F, et al. Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer. Mol Cancer Res. 2006;4(2):79–92.
Article
CAS
PubMed
Google Scholar
Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: archive for functional genomics data sets—update. Nucl Acids Res [Internet]. 2013 1 [cited 2015 Jun 26];41(D1):D991–D995.
Davis AP, Grondin CJ, Lennon-Hopkins K, Saraceni-Richards C, Sciaky D, King BL, et al. The Comparative Toxicogenomics Database’s 10th year anniversary: update 2015. Nucleic Acids Res. 2015;43(Database issue):D914–20.
Article
PubMed Central
PubMed
Google Scholar
The R team. R: a language and environment for statistical computing. R foundation for statistical computing, Vienna, Austria. 2008.
Google Scholar
Carlson M. org.Hs.eg.db: Genome wide annotation for Human. R package version 3.1.2 2015.
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57:289–300.
Google Scholar
Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006;34(Database issue):D668–72.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lam JS, Leppert JT, Vemulapali SN, Shvarts O, Belldegrun AS. Secondary hormonal therapy for advanced prostate cancer. J Urol. 2006;175(1):27–34.
Article
CAS
PubMed
Google Scholar
Thorn CF, Klein TE, Altman RB. PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base. Methods Mol Biol. 2005;311:179–91.
CAS
PubMed
Google Scholar